Various issues of policy or operational nature relating to the structure and implementation of the Drugs Cosmetics Rules at Central or State level are taken up with the authorities through representations and follow-up meetings. Some of the important issues which have been taken up with the authorities in recent times are :

1. Extension of validity of WHO-GMP certificates to five years.

2. Six months grace period needed for implementation of overseas pharmacopoeia.

3. IDMA’s representation on DTAB.

4. Decentralisation of work regarding registration for import of drugs.

5. Delay in testing of drugs.

6. Licence/inspection fees for SSI sector.

7. Reduction in 4 years period for treating a drug as ‘new’ drug.

8. Adoption of manufacturer’s method of analysis in case of dispute.

9. Menace of spurious drugs, etc.